RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Ana M. Espino to Helminth Proteins

This is a "connection" page, showing publications Ana M. Espino has written about Helminth Proteins.
Connection Strength

6.591
  1. Ruiz-Jim?nez C, Celias D, Vald?s B, Ramos-P?rez WD, Cervi L, Espino AM. Fasciola hepatica fatty acid binding protein (Fh12) induces apoptosis and tolerogenic properties in murine bone marrow derived dendritic cells. Exp Parasitol. 2021 Dec; 231:108174.
    View in: PubMed
    Score: 0.786
  2. Figueroa-Santiago O, Espino A. Purification of Native Fasciola hepatica Fatty Acid-Binding Protein and Induction of Alternative Activation of Human Macrophages. Methods Mol Biol. 2020; 2137:149-169.
    View in: PubMed
    Score: 0.691
  3. Figueroa-Santiago O, Espino A. Possible Role for Toll-Like Receptors in Interaction of Fasciola hepatica Excretory-Secretory Products with Human Monocyte Cell Line. Methods Mol Biol. 2020; 2137:171-180.
    View in: PubMed
    Score: 0.691
  4. Aguayo V, Vald?s Fernandez BN, Rodr?guez-Valent?n M, Ruiz-Jim?nez C, Ramos-Ben?tez MJ, M?ndez LB, Espino AM. Fasciola hepatica GST downregulates NF-?B pathway effectors and inflammatory cytokines while promoting survival in a mouse septic shock model. Sci Rep. 2019 02 19; 9(1):2275.
    View in: PubMed
    Score: 0.651
  5. Ramos-Benitez MJ, Ruiz-Jimenez C, Rosado-Franco JJ, Ramos-P?rez WD, Mendez LB, Osuna A, Espino AM. Fh15 Blocks the Lipopolysaccharide-Induced Cytokine Storm While Modulating Peritoneal Macrophage Migration and CD38 Expression within Spleen Macrophages in a Mouse Model of Septic Shock. mSphere. 2018 12 19; 3(6).
    View in: PubMed
    Score: 0.643
  6. Ramos-Ben?tez MJ, Ruiz-Jim?nez C, Aguayo V, Espino AM. Recombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligands. Sci Rep. 2017 07 14; 7(1):5455.
    View in: PubMed
    Score: 0.583
  7. Rivera F, Espino AM. Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica. Exp Parasitol. 2016 Jan; 160:31-8.
    View in: PubMed
    Score: 0.520
  8. Martin I, Cab?n-Hern?ndez K, Figueroa-Santiago O, Espino AM. Fasciola hepatica fatty acid binding protein inhibits TLR4 activation and suppresses the inflammatory cytokines induced by lipopolysaccharide in vitro and in vivo. J Immunol. 2015 Apr 15; 194(8):3924-36.
    View in: PubMed
    Score: 0.496
  9. Cab?n-Hern?ndez K, Gaudier JF, Espino AM. Characterization and differential expression of a ferritin protein from Fasciola hepatica. Mol Biochem Parasitol. 2012 Mar-Apr; 182(1-2):54-61.
    View in: PubMed
    Score: 0.397
  10. Figueroa-Santiago O, Delgado B, Espino AM. Fasciola hepatica saposin-like protein-2-based ELISA for the serodiagnosis of chronic human fascioliasis. Diagn Microbiol Infect Dis. 2011 Jul; 70(3):355-61.
    View in: PubMed
    Score: 0.383
  11. Boukli NM, Delgado B, Ricaurte M, Espino AM. Fasciola hepatica and Schistosoma mansoni: identification of common proteins by comparative proteomic analysis. J Parasitol. 2011 Oct; 97(5):852-61.
    View in: PubMed
    Score: 0.375
  12. Espino AM, Hillyer GV. Molecular cloning of a member of the Fasciola hepatica saposin-like protein family. J Parasitol. 2003 Jun; 89(3):545-52.
    View in: PubMed
    Score: 0.219
  13. Ramos-Ben?tez MJ, Lopez-Cruz LM, Aguayo V, Ruiz-Jimenez C, Espino AM. Cell-free expression, purification and immunoreactivity assessment of recombinant Fasciola hepatica saposin-like protein-2. Mol Biol Rep. 2018 Oct; 45(5):1551-1556.
    View in: PubMed
    Score: 0.156
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support